{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:08:57Z","timestamp":1768313337618,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["4UL1TR000439"],"award-info":[{"award-number":["4UL1TR000439"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 HL123341"],"award-info":[{"award-number":["K23 HL123341"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NR012642"],"award-info":[{"award-number":["R01 NR012642"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56HL126539"],"award-info":[{"award-number":["R56HL126539"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008136","name":"Case Western Reserve University","doi-asserted-by":"publisher","award":["P30 AI36219"],"award-info":[{"award-number":["P30 AI36219"]}],"id":[{"id":"10.13039\/100008136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008136","name":"Case Western Reserve University","doi-asserted-by":"publisher","award":["UL1TR000439"],"award-info":[{"award-number":["UL1TR000439"]}],"id":[{"id":"10.13039\/100008136","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.atherosclerosis.2017.09.030","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T03:46:41Z","timestamp":1506656801000},"page":"74-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effect of statin on arginine metabolites in treated HIV-infection"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-9062","authenticated-orcid":false,"given":"Sahera","family":"Dirajlal-Fargo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"El Kamari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdus","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurshid","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Funderburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Labbato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Pirro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris T.","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Hong","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace A.","family":"McComsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.09.030_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2017.09.030_bib2","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":"Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.09.030_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00019501-200002000-00008","article-title":"Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients","volume":"11","author":"Tabib","year":"2000","journal-title":"Coron. Artery Dis."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.09.030_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jmv.21424","article-title":"Prognostic factors of long-term CD4+count-guided interruption of antiretroviral treatment","volume":"81","author":"Sarmati","year":"2009","journal-title":"J.\u00a0Med. Virol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.09.030_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s","volume":"52","author":"Torriani","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.09.030_bib6","first-page":"183","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi","year":"2005","journal-title":"Vasc. Health Risk Manag."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.09.030_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/138161209787354230","article-title":"Targeting redox signaling in the vascular wall: from basic science to clinical practice","volume":"15","author":"Antoniades","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.09.030_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib9","first-page":"159","article-title":"Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy","volume":"58","author":"Beltowski","year":"2006","journal-title":"Pharmacol. Rep. PR"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.09.030_bib10","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1016\/j.ahj.2006.06.005","article-title":"Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study","volume":"152","author":"Schulze","year":"2006","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.RES.87.2.99","article-title":"LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases","volume":"87","author":"Boger","year":"2000","journal-title":"Circulation Res."},{"key":"10.1016\/j.atherosclerosis.2017.09.030_bib12","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1038\/srep09902","article-title":"A\u00a0systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations","volume":"5","author":"Serban","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.amjcard.2004.03.052","article-title":"Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia","volume":"94","author":"Lu","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.09.030_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1536\/ihj.49.303","article-title":"Short term fluvastatin treatment lowers serum asymmetric dimethylarginine levels in patients with metabolic syndrome","volume":"49","author":"Oguz","year":"2008","journal-title":"Int. Heart J."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.09.030_bib15","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/j.1540-8159.2009.02554.x","article-title":"Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion","volume":"32","author":"Xia","year":"2009","journal-title":"Pacing Clin. Electrophysiol. PACE"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.09.030_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.phrs.2009.07.009","article-title":"Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers","volume":"60","author":"Kurz","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.09.030_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/QAI.0000000000001148","article-title":"Marker of endothelial dysfunction asymmetric dimethylarginine is elevated in HIV infection but not associated with subclinical atherosclerosis","volume":"73","author":"Haissman","year":"2016","journal-title":"J.\u00a0Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/QAI.0b013e318252f99f","article-title":"HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction","volume":"60","author":"Baker","year":"2012","journal-title":"J.\u00a0Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.09.030_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAD.0000000000000885","article-title":"Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV","volume":"30","author":"Hileman","year":"2016","journal-title":"Aids"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.09.030_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/cid\/cit748","article-title":"Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"58","author":"Funderburg","year":"2014","journal-title":"Clin. Infect. Dis. official Publ. Infect. Dis. Soc. Am."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2017.09.030_bib21","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/QAD.0000000000001167","article-title":"Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection","volume":"30","author":"Longenecker","year":"2016","journal-title":"Aids"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.09.030_bib22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/infdis\/jiu012","article-title":"Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy","volume":"209","author":"Eckard","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.09.030_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.09.030_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","article-title":"Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"68","author":"Funderburg","year":"2015","journal-title":"J.\u00a0Acquir. Immune Defic. Syndr."},{"issue":"18","key":"10.1016\/j.atherosclerosis.2017.09.030_bib25","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA's statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am. Statistician"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","article-title":"The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease","volume":"6","author":"Sibal","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.09.030_bib28","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/HYPERTENSIONAHA.108.120352","article-title":"Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study","volume":"52","author":"Chirinos","year":"2008","journal-title":"Hypertension"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2017.09.030_bib29","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/01.CIR.0000101924.04515.2E","article-title":"Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence","volume":"108","author":"Dayoub","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.09.030_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1567-5688(03)00032-1","article-title":"The DDAH\/ADMA\/NOS pathway","volume":"4","author":"Tran","year":"2003","journal-title":"Atheroscler. Suppl."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.09.030_bib31","first-page":"174","article-title":"Changes in inflammation, oxidative stress, mitochondrial DNA content after rosiglitazone in HIV lipoatrophy","volume":"3","author":"Tungsiripat","year":"2012","journal-title":"J.\u00a0AIDS Clin. Res."},{"issue":"18","key":"10.1016\/j.atherosclerosis.2017.09.030_bib32","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","author":"Boger","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.09.030_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.atherosclerosis.2013.04.025","article-title":"Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals","volume":"229","author":"Parikh","year":"2013","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.atherosclerosis.2011.03.035","article-title":"Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus","volume":"217","author":"Jang","year":"2011","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.09.030_bib35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/QAD.0000000000000124","article-title":"Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection","volume":"28","author":"Parikh","year":"2014","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib36","first-page":"222","article-title":"Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA Study","volume":"14","author":"Iribarren","year":"2007","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil. official J. Eur. Soc. Cardiol. Work. Groups Epidemiol. Prev. Cardiac Rehabil. Exerc. Physiol."},{"issue":"9299","key":"10.1016\/j.atherosclerosis.2017.09.030_bib37","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.09.030_bib38","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.107.690016","article-title":"Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study","volume":"116","author":"Juonala","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.atherosclerosis.2010.06.041","article-title":"Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study","volume":"212","author":"Paiva","year":"2010","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/CS20100595","article-title":"Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn study","volume":"121","author":"van der Zwan","year":"2011","journal-title":"Clin. Sci."},{"issue":"1 Pt 2","key":"10.1016\/j.atherosclerosis.2017.09.030_bib41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.HYP.29.1.242","article-title":"Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension","volume":"29","author":"Matsuoka","year":"1997","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.09.030_bib42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/rheumatology\/keu349","article-title":"Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study","volume":"54","author":"Sandoo","year":"2015","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.09.030_bib43","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/ard.2005.036137","article-title":"Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus","volume":"64","author":"Bultink","year":"2005","journal-title":"Ann. Rheum. Dis."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T10:48:10Z","timestamp":1668595690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017313163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":43,"alternative-id":["S0021915017313163"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.09.030","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of statin on arginine metabolites in treated HIV-infection","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}